ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01116622
Recruitment Status : Completed
First Posted : May 5, 2010
Last Update Posted : November 13, 2014
Sponsor:
Collaborators:
Genentech, Inc.
Ligand Pharmaceuticals
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : April 2014